JENNIFER GRAHAM: Open Payments
NPI 1235492778 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,505 in 121 payments from 19 companies in 2025. Trend: 2023 $1,563 · 2024 $2,445 · 2025 $2,505
Food & beverage: $2,505
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 30 | $529 |
| AstraZeneca Pharmaceuticals LP | 16 | $365 |
| GENZYME CORPORATION | 12 | $256 |
| Grifols USA, LLC | 10 | $211 |
| Viatris Specialty LLC | 4 | $187 |
| Merck Sharp & Dohme LLC | 10 | $180 |
| Regeneron Healthcare Solutions, Inc. | 6 | $163 |
| Insmed, Inc. | 10 | $137 |
| Actelion Pharmaceuticals US, Inc. | 3 | $83 |
| Amgen Inc. | 4 | $72 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, Prolastin-C Liquid, YUPELRI, WINREVAIR, Arikayce.
Industry payments across LA — which companies pay providers there.
